As demand for peptide-based APIs grows, selecting the most efficient and cost-effective manufacturing route is critical. This presentation compares linear Solid-Phase Peptide Synthesis (SPPS) with SPPS-based fragment conjugation, focusing on cost and scalability in large-scale production. Through a case study, modeling assumptions, experimental setups, and key efficiency parameters will be explored to guide informed decisions in optimizing peptide API manufacturing strategies.